Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …

Nonalcoholic fatty liver disease (NAFLD), sarcopenia and sarcopenic obesity (SO) are
highly prevalent conditions that may coexist, especially in the aging population, without any …

Skeletal muscle (SM) plays a vital role in energy and glucose metabolism by regulating
insulin sensitivity, glucose uptake, and blood glucose homeostasis. Impaired SM …

Insulin is a critical hormone that promotes energy storage in various tissues, as well as
anabolic functions. Insulin resistance significantly reduces these responses, resulting in …

Sarcopenia derives from the Greek words “sarx”(ie, flesh) and “penia”(ie, deficiency), and
denotes the decline in the quantity (ie, number of motor units) and quality (atrophy of muscle …

Sarcopenic obesity is characterized by concurrent obesity and muscle wasting (sarcopenia)
and is common in the elderly. Sarcopenic obesity has steadily increased as the aging …

Aim: Diabetic sarcopenia leads to disability and seriously affects the quality of life. Currently,
there are no effective therapeutic strategies for diabetic sarcopenia. Our previous studies …

Sarcopenia is a multifactorial condition characterized by loss of muscle mass. It poses
significant health risks in older adults worldwide. Both pharmacological and non …

Sarcopenic obesity (SO) and osteoporosis (OP) are associated with aging and obesity. The
pathogenesis of SO is complex, including glucolipid and skeletal muscle metabolic …

Exercise is recognized to play an observable role in improving human health, especially in
promoting muscle hypertrophy and intervening in muscle mass loss‐related diseases …